Avanos Medical, Inc. (AVNS), AirSculpt Technologies, Inc. (AIRS), and Amphastar Pharmaceuticals, Inc. (AMPH) have been added to the Zacks Rank #5 (Strong Sell) List. This comes as the Zacks Consensus Estimate for Avanos’ current year earnings was revised downward by 31.8% over the last 60 days, while AirSculpt experienced a significant 121.7% downward revision, and Amphastar saw a 23.5% drop in its estimates.
The revisions indicate potential challenges for these companies in meeting earnings expectations, reflecting a broader trend in their respective sectors. Investors should monitor these changes closely for any implications on stock performance.
